Family history of myocardial infarction increases risk of renal dysfunction in middle age

American Journal of Nephrology

Volumn 39, Issue 2, 2014, Pages 85-91

  Christensson, Anders ^a   Melander, Olle ^a   Fjellstedt, Erik ^a   Ohlson Andersson, Maria ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Heredity; Myocardial infarction

Indexed keywords

CREATININE;

ADULT; AGE; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HEREDITY; HIGH RISK PATIENT;

ADULT; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION BARRIER; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; QUESTIONNAIRES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84893171891     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000358259     Document Type: Article

References (30)

1. Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P, Van Lente F, Levey A: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and ESRD in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
3. Swedish Renal Registry (SRR): www.snron-line.se/. Sveriges kommuner och landsting.
4. Hallan SI, Coresh J, Astor BC, Åsberg A, Powe N, Romundstad S, Hallan H, Lydersen S, Hol-men J: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284.
5. Sarnak M, Levey A, Schoolwerth A, Coresh J, Culleton B, Hamm L, McCullough P, Kasiske B, Kelepouris E, Klag M, Parfrey P, Pfeffer M, Spinosa D, Wilson P: Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
6. Ritz E: Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart 2003; 89: 963-964.
7. Christensson A, Savage C, Sjoberg D, Cronin A, O'Brien F, Lowrance W, Nilsson P, Vickers A, Russo P, Lilja H: Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years. Int J Cancer 2013; 133: 1452-1458.
8. Ronco C, Haapio M, House A, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
9. Schrier R: Cardiorenal versus renocardiac syndrome: is there a difference? Nat Clin Pract Nephrol 2007; 3: 637.
10. Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER III: Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 2005; 165: 2299-2304.
11. Korstanje R, DiPetrillo K: Unraveling the genetics of chronic kidney disease using animal models. Am J Physiol Renal Physiol 2004; 287:F347-F352.
12. Perneger TV, Whelton PK, Klag MJ: Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med 1995; 155: 1201-1208.
13. Freedman B, Murea M: Target organ damage in African-American hypertension: role of APOL1. Curr Hypertens Rep 2012; 1: 21-28.
14. Satko S, Sedor J, Iyengar S, Freedman B: Familial clustering of chronic kidney disease. Semin Dial 2007; 20: 229-236.
15. Lei H, Perneger T, Klag M: Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol 1998; 9: 1270-1276.
16. Arnett D, Baird A, Barkley R, Basson C, Boer-winkle E, Ganesh S, Herrington D, Hong Y, Jaquish C, McDermott D, O'Donnell C: Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007; 115: 2878-2901.
17. Kullo I, Ding K: Mechanisms of disease: the genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med 2007; 4: 558-569.
18. Fujimaki T, Kato K, Yoshida T, Oguri M, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Nishigaki Y, Tanaka M, Nozawa Y, Kimura G, Yamada Y: Association of genetic variants with myocardial infarction in Japanese individuals with chronic kidney disease. Thromb Haemost 2009; 101: 963-968.
19. Berglund G, Eriksson KF, Israelsson B, Kjell-ström T, Lindgärde F, Mattiasson I, Nilsson JÅ, Stavenow L: Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 1996; 239: 489-497.
20. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgarde F: Long-term outcome of the Malmo Preventive Project: mortality and cardiovascular morbidity. J Intern Med 2000; 247: 19-29.
21. Levey A, Stevens L, Schmid C, Zhang Y, Castro A 3rd, Feldman H, Kusek J, Eggers P, Van Lente F, Greene T, Coresh J: CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glo-merular filtration rate. Ann Int Med 2009; 150: 604-612.
22. Cockroft DW, Gault MH: Prediction of cre-atinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
23. duBois D, duBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.
24. National Kidney Foundation: KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(suppl 1):S1-S266.
25. Levey AS, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S, Kusek J, Van Lente F: Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
26. Nora J, Lortscher R, Spangler R, Nora A, Kim-berling W: Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980; 61: 503-508.
27. Myocardial Infarction Genetics Consortium: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009; 41: 334-341.
28. Erdmann J, Grosshennig A, Braund P: New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009; 41: 280-282.
29. Helgadottir A, Thorleifsson G, Manolescu A: A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491-1493.
30. Samani N, Erdmann J, Hall A: Genome-wide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453.